SMTL ID : 5fi6.1

Crystal structure of human GAC in complex with inhibitor UPGL_00011: 2-phenyl-~{N}-[5-[[(3~{S})-1-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]ethanamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.52 Å

Oligo State

homo-tetramer

Ligands

2 x 5XY: 2-phenyl-~{N}-[5-[[(3~{S})-1-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]ethanamide(Non-covalent)

5XY.1: 16 residues within 4Å: Chain A: R.258, F.259, K.261, L.262, F.263, L.264, N.265, E.266, Y.335 Chain B: K.261, L.262, F.263, L.264, N.265, E.266, Y.335 10 PLIP interactions: 5 interactions with chain B, 5 interactions with chain A Hydrophobic interactions: B:F.263, B:E.266, A:F.259, A:L.262, A:Y.335 Hydrogen bonds: B:F.263, B:L.264, B:Y.335, A:L.264 pi-Cation interactions: A:K.261 5XY.2: 16 residues within 4Å: Chain A: R.258 Chain B: F.259 Chain C: K.261, L.262, F.263, L.264, N.265, E.266, Y.335 Chain D: K.261, L.262, F.263, L.264, N.265, E.266, Y.335 12 PLIP interactions: 6 interactions with chain D, 4 interactions with chain C, 1 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: D:L.262, D:F.263, D:E.266, C:E.266, A:R.258, B:F.259 Hydrogen bonds: D:F.263, D:L.264, D:Y.335, C:K.261, C:F.263, C:L.264

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McDermott, L.A. et al., Design and evaluation of novel glutaminase inhibitors. Bioorg.Med.Chem. (2016)

Release Date

2016-05-11

Peptides

Glutaminase kidney isoform, mitochondrial: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Glutaminase kidney isoform, mitochondrial

Related Entries With Identical Sequence